A Study to Evaluate ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee
Status:
Terminated
Trial end date:
2018-01-09
Target enrollment:
Participant gender:
Summary
The purpose of this phase 2, randomised, double-blind, placebo controlled, parallel group,
multicentre study is to investigate the efficacy, safety, tolerability and pharmacokinetics
of a compound ONO-4474 in patients with moderate to severe pain due to osteoarthritis of the
knee following 4 weeks of oral administration of ONO-4474.